Angiotensin-II type 1 receptor gene polymorphism and long-term survival in patients with idiopathic congestive heart failure

European Journal of Heart Failure

Volumn 1, Issue 4, 1999, Pages 363-369

  Andersson, Bert ^a   Blange, Irina ^b   Sylvén, Christer ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiomyopathy, congestive; Epidemiology, molecular; Heart failure, congestive; Polymorphism (genetics); Prognosis; Ventricular function, left

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; DNA;

ADULT; AGED; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DISEASE SEVERITY; DNA POLYMORPHISM; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GENOTYPE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; SWEDEN;

ALLELES; FEMALE; GENOTYPE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; STROKE VOLUME; SURVIVAL RATE; SWEDEN;

EID: 0033501322     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(99)00045-8     Document Type: Article

References (31)

1. Cambien F., Alhenc-Gelas F., Herbeth B., Andre J.L., Rakotavao R., Gonzales M.F. et al. Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy study. Am J Hum Genet. 43:1988;774-780.
2. Schunkert H., Hense H.-W., Holmer S.R., Stender M., Perz S., Keil U. et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 330:1994;1634-1638.
3. Lindpaintner K., Pfeffer M.A., Kreutz R., Stampfer M.J., Grodstein F., LaMotte F. et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 332:1995;706-711.
4. Lindpaintner K., Lee M., Larson M.G., Rao V.S., Pfeffer M.A., Ordovas J.M. et al. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med. 334:1996;1023-1028.
5. Samani N.J., Thompson J.R., O'Toole L., Channer K., Wood K.L. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme with myocardial infarction. Circulation. 94:1996;708-712.
6. Andersson B., Sylvén C. The DD genotype of the ACE gene is associated with increased mortality in idiopathic heart failure. J Am Coll Cardiol. 28:1996;162-167.
7. Bonnardeaux A., Davies E., Jeunemaitre X., Fery I., Charru A., Clauser E. et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension. 24:1994;63-69.
8. Amant C., Hamon M., Bauters C., Richard F., Helbecque N., McFadden E.P. et al. The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. J Am Coll Cardiol. 29:1997;486-490.
9. Nakauchi Y., Suehiro T., Yamamoto M., Yasuoka N., Arii K., Kumon Y. et al. Significance of angiotensin I-converting enzyme and angiotensin II type 1 receptor gene polymorphisms as risk factors for coronary heart disease. Atherosclerosis. 125:1996;161-169.
10. Tiret L., Bonnardeaux A., Poirier O., Ricard S., Marques-Vidal P., Evans A. et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet. 344:1994;910-913.
11. Tiret L., Blanc H., Ruidavets J.B., Arveiler D., Luc G., Jeunemaitre X. et al. Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. Projet d'Etude des Genes de l'Hypertension Arterielle Severe a moderee Essentielle. J Hypertens. 16:1998;37-344.
12. Schmidt S., Beige J., Walla-Friedel M., Michel M.C., Sharma A.M., Ritz E. A polymorphism in the gene for the angiotensin II type 1 receptor is not associated with hypertension. J Hypertens. 15:1997;1385-1388.
13. Castellano M., Muiesan M.L., Beschi M., Rizzoni D., Cinelli A., Salvetti M. et al. Angiotensin II type 1 receptor A/C1166 polymorphism. Relationships with blood pressure and cardiovascular structure. Hypertension. 28:1996;1076-1080.
14. Takemoto Y., Sakatani M., Takami S., Tachibana T., Higaki J., Ogihara T. et al. Association between angiotensin II receptor gene polymorphism and serum angiotensin converting enzyme (SACE) activity in patients with sarcoidosis. Thorax. 53:1998;459-462.
15. Pitt B., Segal R., Martinez F.A., Meurers G., Cowley A.J., Thomas I. et al. Randomised trial of losartan vs. captopril in patients over 65 with heart failure (Evaluation of losartan in the elderly study, ELITE). Lancet. 349:1997;747-752.
16. Yusuf S., Maggioni A.P., Held P., Rouleau J.-L. Effects of candesartan, enalapril or their combination on exercise capacity, ventricular function, clinical deterioration and quality of life in heart failure: Randomized evaluation of strategies for left ventricular dysfunction (RESVOLVD). Circulation. 96:1997;I-452.
17. Andersson B., Waagstein F. Spectrum and outcome of congestive heart failure in a hospitalized population. Am Heart J. 126:1993;632-640.
18. Andersson B., Caidahl K., Waagstein F. An echocardiographic evaluation of patients with idiopathic heart failure. Chest. 107:1995;680-689.
19. Andersson B., Caidahl K., Waagstein F. Idiopathic dilated cardiomyopathy among Swedish patients with congestive heart failure. Eur Heart J. 16:1995;53-60.
20. Sahn D.J., DeMaria A., Kisslo J., Weyman A. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation. 58:1978;1072-1083.
21. Valdes-Cruz L.M., Sahn D.J. Two dimensional echo doppler for non-invasive quantitation of cardiac flow: A status report. Mod Concepts Cardiovasc Dis. 51:1982;123-128.
22. Teichholz L.E., Kreulen T., Herman M.V., Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol. 37:1976;7-11.
23. Caidahl K., Eriksson H., Hartford M., Wikstrand J., Wallentin I., Arvidsson A. et al. Dyspnoea of cardiac origin in 67 year old men: (2) relation to diastolic left ventricular function and mass. The study of men born in 1913. Br Heart J. 59:1988;329-338.
24. Katsuya T., Koike G., Yee T.W., Sharpe N., Jackson R., Norton R. et al. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet. 345:1995;1600-1603.
25. Rigat B., Hubert C., Alhenc-Gelas F., Roeckel N., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidylcarboxypeptidase 1). Nucleic Acids Res. 20:1992;1433.
26. Bristow M.R., Ginsburg R., Minobe W., Cubicciotti R.S., Sageman W.S., Lurie K. et al. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N Engl J Med. 307:1982;205-211.
27. Colucci W.S., Alexander R.W., Williams G.H., Rude R.E., Holman B.L., Konstam M.A. et al. Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. N Engl J Med. 305:1981;185-190.
28. Collins S., Caron M.G., Lefkowitz R.J. From ligand binding to gene expression: new insights into the regulation of G-protein-coupled receptors. TIBS. 17:1992;37-39.
29. Linz W., Scholkens B.A., Ganten D. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens. 11:1989;1325-1350.
30. Geisterfer A., Peach M.J., Owens G.K. Angiotensin II induces hypertrophy, not hyperplasia of cultured rat aortic smooth muscle cells. Circ Res. 62:1988;749-756.
31. Daemen M.J.A.P., Lombardi D.M., Bosman F.T., Schwartz S.M. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 68:1991;450-456.